| Pronecrotic mixed lineage kinase domain‐like protein expression is a prognostic biomarker in patients with early‐stage resected pancreatic adenocarcinoma LE Colbert, SB Fisher, CW Hardy, WA Hall, B Saka, JW Shelton, ... Cancer 119 (17), 3148-3155, 2013 | 127 | 2013 |
| In vitro and in vivo enhancement of chemoradiation using the oral PARP inhibitor ABT-888 in colorectal cancer cells JW Shelton, TV Waxweiler, J Landry, H Gao, Y Xu, L Wang, B El-Rayes, ... International Journal of Radiation Oncology* Biology* Physics 86 (3), 469-476, 2013 | 74 | 2013 |
| CHD7 expression predicts survival outcomes in patients with resected pancreatic cancer LE Colbert, AV Petrova, SB Fisher, BG Pantazides, MZ Madden, ... Cancer research 74 (10), 2677-2687, 2014 | 69 | 2014 |
| Lung stereotactic body radiation therapy and concurrent immunotherapy: a multicenter safety and toxicity analysis S Tian, JM Switchenko, ZS Buchwald, PR Patel, JW Shelton, SE Kahn, ... International Journal of Radiation Oncology* Biology* Physics 108 (1), 304-313, 2020 | 66 | 2020 |
| Comparison of image-guided radiotherapy technologies for prostate cancer S Das, T Liu, AB Jani, P Rossi, J Shelton, Z Shi, MK Khan American journal of clinical oncology 37 (6), 616-623, 2014 | 66 | 2014 |
| Concomitant chemotherapy and radiotherapy with SBRT boost for unresectable stage III non–small cell lung cancer: a phase I study KA Higgins, RN Pillai, Z Chen, S Tian, C Zhang, P Patel, S Pakkala, ... Journal of Thoracic Oncology 12 (11), 1687-1695, 2017 | 62 | 2017 |
| Next‐generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy RJ Cassidy, X Zhang, PR Patel, JW Shelton, CE Escott, GL Sica, ... Cancer 123 (19), 3681-3690, 2017 | 34 | 2017 |
| Observations on prostate intrafraction motion and the effect of reduced treatment time using volumetric modulated arc therapy J Shelton, PJ Rossi, H Chen, Y Liu, VA Master, AB Jani Practical radiation oncology 1 (4), 243-250, 2011 | 33 | 2011 |
| Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer WA Hall, AV Petrova, LE Colbert, CW Hardy, SB Fisher, B Saka, ... Oncogene 33 (47), 5450-5456, 2014 | 32 | 2014 |
| Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma DM Marcus, M Lowe, MK Khan, DH Lawson, IR Crocker, JW Shelton, ... American journal of clinical oncology 37 (6), 580-584, 2014 | 30 | 2014 |
| Comparison of vaginal microbiota in gynecologic cancer patients pre‐and post‐radiation therapy and healthy women D Tsementzi, A Pena‐Gonzalez, J Bai, YJ Hu, P Patel, J Shelton, M Dolan, ... Cancer medicine 9 (11), 3714-3724, 2020 | 27 | 2020 |
| Noninvasive evaluation of vaginal fibrosis following radiotherapy for gynecologic malignancies: A feasibility study with ultrasound B‐mode and Nakagami parameter imaging X Yang, P Rossi, DW Bruner, S Tridandapani, J Shelton, T Liu Medical physics 40 (2), 022901, 2013 | 24 | 2013 |
| Reduced acute toxicity associated with the use of volumetric modulated arc therapy for the treatment of adenocarcinoma of the prostate WA Hall, L Colbert, D Nickleach, J Shelton, DM Marcus, J Switchenko, ... Practical radiation oncology 3 (4), e157-e164, 2013 | 16 | 2013 |
| Initial report of a randomized trial comparing conventional-vs conventional plus fluciclovine (18F) PET/CT imaging-guided post-prostatectomy radiotherapy for prostate cancer A Jani, E Schreibmann, S Goyal, H Raghuveer, B Hershatter, PJ Rossi, ... International Journal of Radiation Oncology, Biology, Physics 108 (5), 1397, 2020 | 15 | 2020 |
| Comparisons of depression, sexual function, and quality of life between women with gynecological cancers and race-matched healthy controls J Bai, SM Belcher, R Meador, G Daniel, J Shelton, P Patel, M Dolan, ... Cancer Nursing 44 (2), 116-124, 2021 | 11 | 2021 |
| Anatomic structure-based deformable image registration of brachytherapy implants in the treatment of locally advanced cervix cancer JM Ryckman, JW Shelton, AF Waller, E Schreibmann, K Latifi, R Diaz Brachytherapy 15 (5), 584-592, 2016 | 9 | 2016 |
| Analysis of Radiation Facility Volume and Survival in Men With Lymph Node–Positive Prostate Cancer Treated With Radiation and Androgen Deprivation Therapy SA Patel, S Goyal, Y Liu, D Moghanaki, PR Patel, S Hanasoge, VR Dhere, ... JAMA network open 3 (12), e2025143-e2025143, 2020 | 6 | 2020 |
| Human mesenchymal glioblastomas are characterized by an increased immune cell presence compared to proneural and classical tumors. OncoImmunology. 2019; 8 (11): e1655360 I Kaffes, F Szulzewsky, Z Chen, CJ Herting, B Gabanic, ... | 6 | |
| Deformable MRI-TRUS registration using biomechanically constrained deep learning model for tumor-targeted prostate brachytherapy X Yang, Y Fu, Y Lei, S Tian, T Wang, JW Shelton, A Jani, WJ Curran, ... International Journal of Radiation Oncology, Biology, Physics 108 (3), e339, 2020 | 5 | 2020 |
| Influence of timing between androgen deprivation therapy and external beam radiation therapy in patients with localized, high-risk prostate cancer NS McCall, Y Liu, SA Patel, B Hershatter, D Moghanaki, KD Godette, ... Advances in Radiation Oncology 6 (6), 100803, 2021 | 3 | 2021 |
